Corofenam/CV – A New Era of Antibiotic Therapy
Corofenam/CV is a next-generation β-lactam antibiotic designed for chronic to acute infections, offering broad-spectrum coverage against multi-drug-resistant (MDR) bacteria. It is highly effective in treating urinary tract infections (UTI), upper and lower respiratory tract infections, soft tissue infections, and gynecological infections, with complete coverage against Streptococcus pneumoniae. With its superior efficacy and higher safety profile, Corofenam/CV provides wide-spectrum action against Gram-positive and Gram-negative bacteria, including aerobes and anaerobes. Its low-dose, high-action formula (5-10 mg/kg) ensures better results with fewer side effects compared to conventional antibiotics like meropenem. Administered orally every 12 hours, it delivers a powerful yet safe alternative for effective infection control.
It sis recommended in treating MDR & UTI
to treat upper & Lower respiratory Tract infection
Soft tissue infection
gynecological infection
complete coverage against streptococcus pneumoniae
Oral B Lactam antibiotic 5-10 MG/KG every 12 hourly oral administration
Corofenam comes in two variations to offer targeted and enhanced antibiotic therapy. The Faropenem Sodium 200mg version is a broad-spectrum β-lactam antibiotic effective against Gram-positive, Gram-negative, aerobic, and anaerobic bacteria, making it ideal for general infections. The Faropenem Sodium 200mg + Potassium Clavulanate 125mg combination enhances efficacy by inhibiting β-lactamase enzymes, making it more effective against drug-resistant bacteria in severe or complicated infections like MDR-UTI, respiratory tract infections, and soft tissue infections. This dual approach ensures superior efficacy, higher safety, and better clinical outcomes, making Corofenam the preferred choice for physicians treating a wide range of infections.
Corofenam/CV contains Faropenem, a β-lactam antibiotic with broad-spectrum activity against Gram-positive, Gram-negative, aerobic, and anaerobic bacteria. It is highly effective in treating infections resistant to conventional antibiotics, including Multi-Drug Resistant (MDR) Urinary Tract Infections (UTIs), respiratory tract infections, and soft tissue infections. The addition of Potassium Clavulanate in Corofenam/CV further enhances its efficacy by inhibiting β-lactamase-producing bacteria, ensuring complete bacterial eradication.
Unlike traditional carbapenems, Corofenam exhibits a better safety profile with minimal gastrointestinal side effects. Its oral administration ensures better patient tolerance, reducing the risk of diarrhea, nausea, or abdominal discomfort. The precise formulation allows for better absorption, ensuring higher drug efficacy with reduced systemic toxicity, making it a safer and more effective choice for a wide range of infections.
Q
What is Corofenam and how does it work?
A
Corofenam is a broad-spectrum β-lactam antibiotic containing Faropenem, which effectively treats bacterial infections by inhibiting bacterial cell wall synthesis. It is highly effective against Gram-positive, Gram-negative, aerobic, and anaerobic bacteria, making it a preferred choice for respiratory, urinary tract, and soft tissue infections.
Q
What are the key benefits of Corofenam compared to other antibiotics?
A
Corofenam offers higher potency at lower doses (5-10 mg/kg) compared to other carbapenems like Meropenem (12-24 mg/kg). It has a superior safety profile, minimal gastrointestinal side effects, and oral administration, making it a convenient alternative to injectable antibiotics for multi-drug resistant infections.
Q
When should Corofenam be used?
A
Corofenam is recommended for treating MDR urinary tract infections, upper & lower respiratory tract infections, gynecological infections, and soft tissue infections. It provides complete coverage against Streptococcus pneumoniae and β-lactamase-producing bacteria, making it effective in both acute and chronic bacterial infections.